NKGen Biotech to Present Troculeucel Mechanism Data in Alzheimer’s and Frontotemporal Dementia at the Neuroimmunology Drug Development Summit

Go back to NKGen Biotech to Present Troculeucel Mechanism Data in Alzheimer’s and Frontotemporal Dementia at the Neuroimmunology Drug Development Summit
(NASDAQ: NKGN) Delayed: 0.19 --0 (-0%)
Previous Close $0.19    52 Week High
Open $0.19    52 Week Low
Day High $0.19    P/E N/A 
Day Low $0.19    EPS
Volume 9,221